Clinical Trials Logo

Idiopathic Solar Urticaria clinical trials

View clinical trials related to Idiopathic Solar Urticaria.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT00483496 Completed - Clinical trials for Idiopathic Solar Urticaria

Evaluation of the Protection Activity of Microfine Titanium Dioxide (Ti02), Pigmentary Ti02 and Bisoctrizole and Their Combinations in Voluntary Patients With Idiopathic Solar Urticaria (SU)

Start date: September 2007
Phase: Phase 2
Study type: Interventional

Commercially available external photoprotectors (EP) do not provide adequate protection against ultraviolet A (UVA) and visible wavelengths. The proposed medicinal product V0096 CR (formula RV3131A-MV1166) is a broad spectrum EP (bsEP). The rationale for the use of V0096 CR (formula RV3131A-MV1166) in the proposed condition is based on its ability to broadly block the UVA radiations and visible light that are known to trigger solar urticaria (SU).